产品编号:S870002
产品规格:25mg
产品价格:面议
| 标准品编号: | S870002 |
| 名称: | Suvorexant-d6 |
| 别名: | [(7R)-4-(5-Chloro-2-benzoxazolyl)hexahydro-7-methyl-1H-1,4-diazepin-1-yl][5-methyl-d3-2-(2H-1,2,3-triazol-2-yl)phenyl-d3]-methanone;5-Chloro-2-[(5R)-5-methyl-4-[5-methyl-d3-2-(2H-1,2,3-triazol-2-yl)benzoyl-d3]-1,4-diazepan-1-yl]-1,3-benzoxazole; MK 4305-d6; [(R)-4-(5-Chloro-benzooxazol-2-yl)-7-methyl-[1,4]diazepan-1-yl]-(5-methyl-d3-2-[1,2,3]triazol-2-yl-phenyl-d3)-methanone |
| 参考CAS号: | 类似: 1030377-33-3 |
| 分子式: | C₂₃H₁₇D₆ClN₆O₂ |
| 分子量: | 456.96 |
| 类别: | Building Blocks; Isotopic Labeled Analogues; |
| 应用: | Suvorexant-d6 is the labeled analog of Suvorexant (S870000), a dual (non-selective) orexin receptor antagonist in development by Merck & Co. for the treatment of insomnia. It works by turning off wakefulness rather than by inducing sleep. Users of higher doses had an increased rate of suicidal ideation. |
| 参考文献 | |